|
Volumn 62, Issue 3, 2000, Pages 245-252
|
Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer
a a a a a |
Author keywords
Antibody; Breast cancer; HER 2 neu; Immunity; Ovarian cancer; T cell
|
Indexed keywords
CANCER VACCINE;
EPITOPE;
GAMMA INTERFERON;
HLA A2 ANTIGEN;
IMMUNOGLOBULIN G ANTIBODY;
ONCOPROTEIN;
ADULT;
ADVANCED CANCER;
ARTICLE;
BREAST CANCER;
CANCER IMMUNOLOGY;
CANCER RECURRENCE;
CLINICAL ARTICLE;
CYTOKINE RELEASE;
FEMALE;
GENE OVEREXPRESSION;
HUMAN;
IMMUNE RESPONSE;
IMMUNOMODULATION;
MINIMAL RESIDUAL DISEASE;
ONCOGENE NEU;
OVARY CANCER;
PRIORITY JOURNAL;
ADENOCARCINOMA;
ADULT;
AGED;
BREAST NEOPLASMS;
CASE-CONTROL STUDIES;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
MIDDLE AGED;
OVARIAN NEOPLASMS;
RECEPTOR, ERBB-2;
|
EID: 0033754789
PISSN: 01676806
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1006438507898 Document Type: Article |
Times cited : (146)
|
References (18)
|